You are here

Novo Nordisk

As Catalent prepares to join Novo family, CDMO's sales continue to slide

Fierce Pharma

Fri, 02/9/24 - 11:21 am

New weight-loss drugs linked to lower risk of depression: study

Axios

Fri, 02/9/24 - 11:12 am

Here's Why Merck, Eli Lilly, and Novo Nordisk Stocks Rose 11% Last Month

Motley Fool

Thu, 02/8/24 - 10:01 pm

Novo Nordisk CEO Jørgensen nets a 13% raise for 2023 amid soaring demand for Wegovy, Ozempic

Fierce Pharma

Wed, 02/7/24 - 09:15 pm

Lars Fruergaard Jorgensen

FDA finds control lapses at Catalent plant being sold to Novo

Reuters

Tue, 02/6/24 - 11:36 pm

drug manufacturing

Eli Lilly mounts clinical and commercial case for tirzepatide as Mounjaro, Zepbound chalk up major gains

Fierce Pharma

Tue, 02/6/24 - 09:33 am

Novo Holdings acquires Catalent in $16.5B deal, aiming to boost Wegovy production as demand soars

Medical Marketing and Media

Mon, 02/5/24 - 11:06 pm

drug manufacturing

Could Novo, Lilly become first trillion-dollar healthcare companies?

Pharma Voice

Mon, 02/5/24 - 10:30 am

Novo Nordisk parent to buy Catalent for $16.5 billion to expand Wegovy supply

CNBC

Mon, 02/5/24 - 10:10 am

drug manufacturing

Could Abbott Labs Be the Next Big Winner in the Billion-Dollar Weight Loss Market?

Motley Fool

Fri, 02/2/24 - 11:50 am

Novo Nordisk doubles stock of Wegovy starter doses but supply constraints persist: CEO

Fierce Pharma

Wed, 01/31/24 - 11:56 am

Novo Nordisk R&D spend jumps 35% thanks to soaring sales as oral obesity plans advance

Fierce Biotech

Wed, 01/31/24 - 11:55 am

As AstraZeneca gears up for courtroom showdown over IRA, Novo's case faces separate HHS rebuke

Fierce Pharma

Tue, 01/30/24 - 09:26 pm

Inflation Reduction Act

Will Novo Nordisk Be a $1 Trillion Company by 2030?

Motley Fool

Tue, 01/30/24 - 10:40 am

2 Rising Biotechs That Could Become the Next Novo Nordisk

Motley Fool

Mon, 01/29/24 - 11:04 am

Madrigal Pharmaceuticals

Viking Therapeutics

Novo Nordisk Puts Pharma Peers in the Shade as Key Earnings Reports Awaited

Yahoo/Bloomberg

Sun, 01/28/24 - 06:27 pm

No decision yet on Wegovy heart benefits from EU drug regulator

Reuters

Fri, 01/26/24 - 11:16 am

Many patients keep weight off after stopping anti-obesity meds: study

Axios

Wed, 01/24/24 - 10:44 am

Novo Nordisk Inks Potential $255M Deal with EraCal, Targets Another Obesity Asset

BioSpace

Tue, 01/23/24 - 06:02 pm

EraCal Therapeutics

New Wegovy TV Commercial Launched After Pause to Deal with High Demand

Xtalks

Sun, 01/21/24 - 05:20 pm

Pages